Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 3
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01478061Phase 4Completed

Multi-center Assessment of Grafts in Coronaries: Long-term Evaluation of the C-Port Device

Role: lead

NCT00292500Not ApplicableTerminated

Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II

Role: lead

NCT01476761Phase 4Completed

MicroCutter in Surgical Stapling - European Trial I

Role: lead

NCT00355563Phase 3Completed

Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery

Role: lead

All 4 trials loaded